tiprankstipranks
Noevir Holdings Co., Ltd. (JP:4928)
:4928
Japanese Market
Want to see JP:4928 full AI Analyst Report?

Noevir Holdings Co., Ltd. (4928) Price & Analysis

0 Followers

4928 Stock Chart & Stats

¥4580.00
-¥80.00(-1.65%)
At close: 4:00 PM EST
¥4580.00
-¥80.00(-1.65%)

Bulls Say, Bears Say

Bulls Say
Revenue GrowthConsistent revenue growth indicates a strong market position and effective product strategy, supporting long-term business sustainability.
Balance Sheet HealthA low debt-to-equity ratio minimizes financial risk, providing stability and flexibility for future investments and growth.
Profit MarginsHigh profit margins reflect effective cost control and pricing power, contributing to sustained profitability and competitive advantage.
Bears Say
Free Cash Flow Growth ChallengesNegative free cash flow growth can limit the company's ability to invest in new opportunities and may impact long-term financial flexibility.
Operational Efficiency PressureDeclining EBIT and EBITDA margins suggest potential inefficiencies, which could affect profitability if not addressed.
Cash Flow ConversionDifficulty in converting earnings to cash may indicate operational inefficiencies, affecting liquidity and investment capacity.

Noevir Holdings Co., Ltd. News

4928 FAQ

What was Noevir Holdings Co., Ltd.’s price range in the past 12 months?
Noevir Holdings Co., Ltd. lowest stock price was ¥4190.00 and its highest was ¥4795.00 in the past 12 months.
    What is Noevir Holdings Co., Ltd.’s market cap?
    Noevir Holdings Co., Ltd.’s market cap is ¥149.09B.
      When is Noevir Holdings Co., Ltd.’s upcoming earnings report date?
      Noevir Holdings Co., Ltd.’s upcoming earnings report date is Aug 03, 2026 which is in 37 days.
        How were Noevir Holdings Co., Ltd.’s earnings last quarter?
        Noevir Holdings Co., Ltd. released its earnings results on May 13, 2026. The company reported ¥40.89 earnings per share for the quarter, beating the consensus estimate of N/A by ¥40.89.
          Is Noevir Holdings Co., Ltd. overvalued?
          According to Wall Street analysts Noevir Holdings Co., Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Noevir Holdings Co., Ltd. pay dividends?
            Noevir Holdings Co., Ltd. pays a Notavailable dividend of ¥228 which represents an annual dividend yield of 5%. See more information on Noevir Holdings Co., Ltd. dividends here
              What is Noevir Holdings Co., Ltd.’s EPS estimate?
              Noevir Holdings Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Noevir Holdings Co., Ltd. have?
              Noevir Holdings Co., Ltd. has 34,156,624 shares outstanding.
                What happened to Noevir Holdings Co., Ltd.’s price movement after its last earnings report?
                Noevir Holdings Co., Ltd. reported an EPS of ¥40.89 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.917%.
                  Which hedge fund is a major shareholder of Noevir Holdings Co., Ltd.?
                  Currently, no hedge funds are holding shares in JP:4928
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Noevir Holdings Co., Ltd.

                    Noevir Holdings Co., Ltd. is a diversified Japanese conglomerate involved in the creation, production, and distribution of cosmetics, pharmaceuticals, and health food items. Its operations span a wide international footprint, including key markets such as Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, Canada, and Russia. The company's Cosmetics division focuses on developing and manufacturing skincare lines, featuring popular brands like Noevir and Nameraka Honpo. It also offers NOV hypoallergenic products and provides contract manufacturing services for cosmetic and quasi-drug formulations. Within its Pharmaceutical & Health Food segment, Noevir produces items such as Nanten Nodo Ame cough drops and functional beverages like Min Min Da Ha. This division also supplies a range of over-the-counter medications, including cold remedies, eye drops, and digestive aids, alongside various nutritional supplements. The "Other" segment broadens the company's scope through the sale and leasing of apparel and aircraft. Furthermore, the company is involved in manufacturing and selling toiletries, procuring and distributing makeup products and containers, and conducting market research. Its extensive aviation services encompass air transport, charter flight operations, ground handling, hanger rentals, and aircraft flight training, in addition to undertaking other aviation-related tasks. Noevir distributes its diverse product portfolio through multiple channels, including pharmacies, specialized retail outlets, general merchandise stores, supermarkets, e-commerce platforms, convenience stores, and a network of approximately 2,000 Noevir beauty studios and proprietary retail locations. Established in Tokyo, Japan, in 1964, Noevir Holdings Co., Ltd. maintains its headquarters there.

                    Noevir Holdings Co., Ltd. (4928) Earnings & Revenues

                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Kao
                    Kose
                    Pola Orbis Holdings
                    Shiseido Company,Limited

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks